PANalytical and Spectris Acquire Pixirad Srl
PANalytical has today confirmed that its parent company Spectris plc has acquired Pixirad Srl., an Italian technology company that develops and distributes high performance X-ray detectors. The business will be integrated into PANalytical within Spectris’ Materials Analysis division. Pixirad was established in 2012 under the spin-off programme of the Instituto Nationale di Fisica Nucleare (INFN). The detector know-how was originally developed through research into advanced particle physics and space research technologies and has been further improved by Pixirad for use with high energetic X-rays.
PANalytical sells the Pixirad detectors as a top-of-the-range option for its Empyrean X-ray diffraction (XRD) instrument, used for various materials analysis applications. An example of the exciting applications for the Pixirad detector-enabled Empyrean is the study of the characteristics of Li-ion batteries as they are run through repeated charge-discharge cycles. Demand for Li-ion batteries and the applications they are used in are growing significantly. The added insight brought from the Empyrean instrument helps developers and manufacturers understand the causes of performance reduction thereby demonstrating how technological advances originating from fundamental research in the field of nuclear physics can be made relevant for solving societal problems.
The combination of Pixirad’s know-how with PANalytical’s expertise in solutions utilising advanced X-ray detectors will result in rapid expansion of the range applications addressed by existing and future instruments. Spectris is a well-respected and long-established supplier of productivity-enhancing instrumentation and controls. Headquartered and listed in the UK.
This article has been republished from materials provided by PANalytical. Note: material may have been edited for length and content. For further information, please contact the cited source.
Test For Designer Drugs Could Help Treat Overdose PatientsNews
Medical professionals are scrambling to meet the growing demand for emergency room treatment, but they’re hampered by the lack of a quick and easy test to screen patients for “designer” drugs. Chemists have now developed such a test and are refining it with the hope that hospitals could eventually use it to choose the appropriate treatment.READ MORE
Promise for Combating Harmful Algal BloomsNews
A cheap, safe and effective method of dealing with harmful algal blooms is on the verge of being introduced following successful field and lab tests. Moves to adopt use of hydrogen peroxide (H2O2) as an effective treatment against toxic algae are already underway following the results of new research.READ MORE
The Smoke Screen - Sensor Arms Race is OnNews
The military uses smoke grenades in dangerous situations to provide cover for people and tanks on the move. But increasingly, sensors can now go beyond the visible range into the infrared (IR) region of the spectrum. Today, researchers report developing a new kind of smoke that obscures both visible and IR detection.READ MORE
Comments | 0 ADD COMMENT
11th International Conference and Exhibition on Metabolomics & Systems Biology
May 17 - May 19, 2018
World Congress on Pathology and Laboratory Medicine
Sep 10 - Sep 11, 2018